CytoHealth

Home
Malaysia
Kuala Lumpur
CytoHealth

Discovering the Transformative Power of
Regenerative Medicine with Evidence-based Solutions

MY CYTOHEALTH SDN BHD
[Reg. No. 202001033724 (1390045-T)]

My CytoHealth Sdn Bhd [Reg. No. 202001033724 (1390045-T)], founded in 2020, is one of the Malaysia leading bioprocessing company that places great emphasis on research and continuous development. CytoHealth strongly believes in facts, data, and evidence-based solutions; hence, we always deliver our best services and expertise in bioprocessing for regenerative medicine and immunotherapy. We partne

r with medical facilities, research institutions, and universities to advance the frontiers of knowledge and medical innovation in these fields. CytoHealth trusts in local development and we are dedicated to moving laboratory discoveries from lab scale to real-life applications. Know more about us: https://linktr.ee/cytohealth

31/07/2026

𝗙𝗿𝗼𝗺 𝗩𝗼𝗹𝘂𝗺𝗲 𝘁𝗼 𝗩𝗮𝗹𝘂𝗲: 𝗔 𝗗𝗲𝗳𝗶𝗻𝗶𝗻𝗴 𝗠𝗼𝗺𝗲𝗻𝘁 𝗳𝗼𝗿 𝗠𝗮𝗹𝗮𝘆𝘀𝗶𝗮𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 ✨
We've wrapped up the 32nd APHM International Healthcare Exhibition and Conference 2026 with gratitude, meaningful connections, and fresh inspiration.

Officially officiated by YB Datuk Seri Haji Dr. Dzulkefly bin Ahmad, Minister of Health Malaysia, this year's conference centred on "From Volume to Value: Measuring What Matters in Healthcare Performance," highlighting the need for healthcare to move beyond volume-driven metrics towards value-based care and sustainable impact.

At CytoHealth, the message resonates deeply with our mission because we believe true value in regenerative medicine doesn't begin at the bedside, but it begins upstream.

Over the past three days, we had the privilege of engaging with healthcare professionals, researchers, and industry leaders while showcasing:
⭐CytoHealth's patent-granted exosome freeze-drying technology
⭐Malaysia's first integrated freeze-drying system within a CGTP-compliant cleanroom

Those conversations reaffirmed our belief that advancing regenerative medicine is built on three critical pillars:
✅Evidence-based science
✅Reproducible bioprocessing
✅Translational excellence

Thank you to everyone who visited our booth and shared meaningful conversations with us. Your support continues to strengthen our commitment to bioprocessing excellence, scientific integrity, and driving what truly matters in regenerative medicine.

Together, let's continue shaping a future where healthcare impact is driven not by volume, but by the value behind every innovation. 💪

Until next time, APHM 2026!

30/07/2026

𝗠𝗲𝗲𝘁 𝗖𝘆𝘁𝗼𝗛𝗲𝗮𝗹𝘁𝗵 𝗮𝘁 𝘁𝗵𝗲 𝟯𝟮𝗻𝗱 𝗔𝗣𝗛𝗠 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 & 𝗘𝘅𝗵𝗶𝗯𝗶𝘁𝗶𝗼𝗻 𝟮𝟬𝟮𝟲! 🤩

Two incredible days have flown by, and today marks the final day. Thank you to everyone who has stopped by our booth to explore our latest advancements in Exosome Bioprocessing.

If you haven't had the chance to visit us yet, there's still time! Visit us today at 𝗕𝗼𝗼𝘁𝗵 𝟰𝟬𝟲𝟮 to meet our team and discover how bioprocessing excellence and science-driven technology are helping shape the future of regenerative medicine, creating meaningful impact in healthcare.

📅 28–30 July 2026
🕤 9:30 AM – 5:00 PM
📍 Ground Floor, Kuala Lumpur Convention Centre
📌Booth 4062 | Hall 4

We look forward to welcoming you on the final day of APHM 2026!

20/07/2026

𝗧𝗵𝗲 𝗔𝗣𝗛𝗠 𝟮𝟬𝟮𝟲 𝗰𝗼𝘂𝗻𝘁𝗱𝗼𝘄𝗻 𝗶𝘀 𝗼𝗻! 🤩

We are excited to announce that CytoHealth will be exhibiting at the 𝟯𝟮𝗻𝗱 𝗔𝗣𝗛𝗠 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝟮𝟬𝟮𝟲 — Malaysia's premier healthcare exhibition, bringing together healthcare leaders and industry partners to explore this year’s theme: “From Volume to Value: Measuring What Truly Matters in Healthcare Performance.”

📅 28–30 July 2026
📌 Kuala Lumpur Convention Centre (KLCC)

Meet our team at Booth 4062, Hall 5, and discover how CytoHealth's proprietary exosome bioprocessing technologies and evidence-based solutions are contributing to what truly matters in healthcare.

🔗 Register here: www.aphmconferences.com
See you at APHM 2026!

07/07/2026

𝗠𝗲𝗮𝗻𝗶𝗻𝗴𝗳𝘂𝗹 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀 𝗺𝗼𝘃𝗲𝘀 𝗳𝗮𝘀𝘁𝗲𝗿 𝘄𝗵𝗲𝗻 𝗲𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺𝘀 𝗺𝗼𝘃𝗲 𝘁𝗼𝗴𝗲𝘁𝗵𝗲𝗿💪

CytoHealth was honoured to be part of the recently concluded 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗼𝗳 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 & 𝗛𝗲𝗮𝗹𝘁𝗵 𝟮𝟬𝟮𝟲 (𝗶𝗖𝗼𝗠𝗲𝗱𝗛 𝟮𝟬𝟮𝟲), organized by the Faculty of Medicine, Universiti Kebangsaan Malaysia - UKM, at Putrajaya Marriott Hotel.

Moderated by Prof. Dr. Mohd Fauzi Mh Busra (Deputy Director of INOVASI@UKM), and Dr. Manira Maarof (Head of Department of Tissue Engineering & Regenerative Medicine, UKM), our CytoHealth CEO, Dr. Liyin Wong, joined the symposium as one of the esteemed speakers alongside our Project Manager, Mr. Ts. Benson Koh, Dr. Lim Moon Nian from Institute for Medical Research (IMR), and Mr. Ts. Ezekiel Lim from Bioeconomy Corporation to discuss one question that matters:

𝗪𝗵𝗲𝗿𝗲 𝗮𝗿𝗲 𝘁𝗵𝗲 𝗿𝗲𝗮𝗹 𝗴𝗮𝗽𝘀 𝗶𝗻 𝘁𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗻𝗴 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝗶𝗲𝘀 𝗶𝗻𝘁𝗼 𝗿𝗲𝗮𝗹-𝘄𝗼𝗿𝗹𝗱 𝗶𝗺𝗽𝗮𝗰𝘁?

Bringing together perspectives from academia, industry, and ecosystem partners, the discussion explored the challenges throughout the science translation journey, from discovery and bioprocessing scale-up to commercialization.

One message resonated throughout the session:
𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗿𝗲𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝘃𝗲 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗶𝗻 𝗠𝗮𝗹𝗮𝘆𝘀𝗶𝗮 𝗶𝘀 𝗻𝗼𝘁 𝘁𝗵𝗲 𝘄𝗼𝗿𝗸 𝗼𝗳 𝗮 𝘀𝗶𝗻𝗴𝗹𝗲 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆, 𝗮 𝘀𝗶𝗻𝗴𝗹𝗲 𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝘆, 𝗼𝗿 𝗮 𝘀𝗶𝗻𝗴𝗹𝗲 𝗼𝗿𝗴𝗮𝗻𝗶𝘇𝗮𝘁𝗶𝗼𝗻.

It requires:
✅ Researchers pushing the boundaries of science
✅ Industry translating innovation into scalable solutions
✅ Government & ecosystem partners supporting biotechnology growth

Once again, thank you to the organizer, moderators, speakers, and participants for making this a meaningful and inspiring discussion.

𝗕𝗲𝗰𝗮𝘂𝘀𝗲 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗶𝘀 𝗼𝗻𝗹𝘆 𝘁𝗵𝗲 𝗯𝗲𝗴𝗶𝗻𝗻𝗶𝗻𝗴.
𝗧𝗼𝗴𝗲𝘁𝗵𝗲𝗿, 𝘄𝗲 𝘁𝘂𝗿𝗻 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝗶𝗲𝘀 𝗶𝗻𝘁𝗼 𝗶𝗺𝗽𝗮𝗰𝘁.

25/06/2026

Scientific discovery is often celebrated as the finish line.
✅ A breakthrough.
✅ A publication.
✅ A milestone.

But in the biotechnology and biologics sectors, these are often only the beginning. The journey toward real-world impact brings a different set of questions:

🤔 Can it be reproduced?
🤔 Can it be scaled?
🤔 Can it remain consistent?

Because discoveries alone do not transform healthcare. It is what happens after discovery that determines whether innovation can truly make a difference.

At CytoHealth, this perspective continues to shape how we approach bioprocessing in regenerative medicine with evidence-based solutions.

𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗶𝘀 𝗼𝗻𝗹𝘆 𝘁𝗵𝗲 𝗯𝗲𝗴𝗶𝗻𝗻𝗶𝗻𝗴.
𝗧𝗵𝗲 𝗶𝗺𝗽𝗮𝗰𝘁 𝗶𝘀 𝗼𝗻𝗹𝘆 𝗷𝘂𝘀𝘁 𝗯𝗲𝗴𝗶𝗻𝗻𝗶𝗻𝗴.

19/06/2026

𝗧𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗻𝗴 𝗥𝗲𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝘃𝗲 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗶𝗻 𝗠𝗮𝗹𝗮𝘆𝘀𝗶𝗮, 𝗕𝘂𝘁 𝗛𝗼𝘄?🤔
While scientific discoveries continue to advance, translating them into meaningful real-world impact requires more than research alone.

As part of the 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗼𝗳 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 & 𝗛𝗲𝗮𝗹𝘁𝗵 𝟮𝟬𝟮𝟲 (iCoMedH 2026) organized by Universiti Kebangsaan Malaysia - UKM, CytoHealth is proud to host the symposium, "Translating Regenerative Medicine in Malaysia: From Research to Real-World Impact", bringing together leaders from industry, research, and ecosystem stakeholders to discuss the collaborative effort needed to advance regenerative medicine in Malaysia.

📅 4 July 2026, Saturday
⏱️ 10:30 am - 11:30 am
📍 Putrajaya Marriott Hotel, Malaysia

During the symposium, our CEO, Dr. Wong Li Yin, will share an industry perspective on the operational, commercialization and scalability challenges that often emerge after scientific discovery. We are also pleased to welcome speakers from the Institute for Medical Research and the Bioeconomy Corporation, who will share a research translation case study and discuss the role of Bioeconomy Corporation in advancing Malaysia’s biotechnology growth.

Join us at the iCoMedH 2026 as we continue the conversation on moving scientific discoveries beyond the laboratory and into sustainable real-world impact!

👉𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗵𝗲𝗿𝗲: https://icomedh2026.com/

24/05/2026

𝗪𝗿𝗮𝗽𝗽𝗶𝗻𝗴 𝗨𝗽 𝗛𝗲𝗮𝗹𝘁𝗵 𝗦𝘂𝗺𝗺𝗶𝘁 𝗔𝘀𝗶𝗮 𝟮𝟬𝟮𝟲! ✨
Following an impactful three days from 20–22 May, CytoHealth was proud to be part of the summit, jointly organized by Qube Integrated Malaysia and Green Wellness Malaysia — bringing together healthcare professionals and key industries to explore the future of regional healthcare and wellness in Asia.

The summit highlighted a growing convergence across the landscape, driven by a collective commitment toward scientific advancement, technology, and evidence-driven innovation solutions.

During the event, our team was honored to share our 𝗽𝗮𝘁𝗲𝗻𝘁-𝗴𝗿𝗮𝗻𝘁𝗲𝗱 𝗲𝘅𝗼𝘀𝗼𝗺𝗲 𝗳𝗿𝗲𝗲𝘇𝗲-𝗱𝗿𝘆𝗶𝗻𝗴 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 with the Deputy Minister of Health Malaysia, Yang Berhormat Dato’ Hajjah Hanifah Hajar Taib. As a BioNexus Status company and one of the few Malaysian bioprocessing players on the exhibition floor, it was highly encouraging to witness the growing recognition of robust bioprocessing technologies as part of the broader healthcare conversation, bridging the gap between medical science and real-world healthcare applications. ✨

Thank you to the organizers, and to everyone who visited our booth, shared insights, and explored potential synergies with us.

𝗧𝗼𝗴𝗲𝘁𝗵𝗲𝗿, 𝗹𝗲𝘁 𝘂𝘀 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲 𝘁𝗼 𝗮𝗱𝘃𝗮𝗻𝗰𝗲 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗳𝗿𝗼𝗺 𝗯𝗲𝗻𝗰𝗵 𝘁𝗼 𝗯𝗲𝗱𝘀𝗶𝗱𝗲, 𝗱𝗿𝗶𝘃𝗲𝗻 𝗯𝘆 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗿𝗲𝗹𝗲𝘃𝗮𝗻𝗰𝗲 𝗮𝗻𝗱 𝘀𝗰𝗮𝗹𝗮𝗯𝗹𝗲 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆. 💪

𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿, 𝗖𝗼𝗻𝗻𝗲𝗰𝘁, 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗲.

22/05/2026

𝗪𝗵𝗮𝘁 𝗱𝗼𝗲𝘀 𝗶𝘁 𝗿𝗲𝗮𝗹𝗹𝘆 𝘁𝗮𝗸𝗲 𝘁𝗼 𝗯𝘂𝗶𝗹𝗱 𝗮 𝘀𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗹𝗲 𝗯𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝘀 𝗰𝗼𝗺𝗽𝗮𝗻𝘆?

After 5 years, our CEO 𝗗𝗿. 𝗟𝗶𝘆𝗶𝗻 𝗪𝗼𝗻𝗴, shares her reflections on what half a decade in regenerative medicine has truly taught us:

• Innovation is hard, but reproducibility is harder.
• Real sustainability comes from systems, not breakthroughs.
• The power of 1% improvements repeated daily can compound into long-term competitive advantage.
• Ecosystem-building matters just as much as company-building.

5 years of science translation. This is not just a milestone reflection. It is the operating philosophy behind CytoHealth.

𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗿𝘁𝗶𝗰𝗹𝗲: https://www.linkedin.com/feed/update/urn:li:activity:7463558940128092160

20/05/2026

Behind every healthcare advancement are years of scientific evaluation, validation, and refinement.

This International Clinical Trials Day, we recognize the importance of rigorous science, responsible development, and the continuous pursuit of evidence beyond the laboratory.

𝗙𝗿𝗼𝗺 𝗟𝗮𝗯 𝘁𝗼 𝗟𝗶𝗳𝗲.
𝗪𝗶𝘁𝗵 𝗘𝘃𝗶𝗱𝗲𝗻𝗰𝗲-𝗕𝗮𝘀𝗲𝗱 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀.

11/05/2026

𝗞𝗶𝗰𝗸𝘀𝘁𝗮𝗿𝘁𝗶𝗻𝗴 𝗼𝘂𝗿 𝗳𝗶𝗿𝘀𝘁 𝗲𝘅𝗵𝗶𝗯𝗶𝘁𝗶𝗼𝗻 𝗼𝗳 𝟮𝟬𝟮𝟲! 🤩
CytoHealth is excited to exhibit at Health Summit Asia (HSA), the 26th SE-Asian Healthcare & Pharma Show, taking place from 20–22 May at the Kuala Lumpur Convention Centre (KLCC).

In collaboration with SEACare and the International Wellness Expo (IWE), the summit brings together the healthcare, medical, pharmaceutical, and wellness sectors to showcase the future transformation of healthcare.

Visit us at 𝗕𝗼𝗼𝘁𝗵 𝟳𝗙𝟬𝟳, 𝗛𝗮𝗹𝗹 𝟳 to discover how CytoHealth’s proprietary technologies are translating regenerative medicine science into reproducible and evidence-driven healthcare applications through controlled bioprocessing systems.

We look forward to seeing you there!

Address

Plaza Hamodal, Lot No. 15, Jalan 13/2, Section 13
Kuala Lumpur
46200

Website

https://mycytohealth.com/

Alerts

Be the first to know and let us send you an email when CytoHealth posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to CytoHealth:

Want your business to be the top-listed Engineering Company in Kuala Lumpur?